Summary
In three consecutive studies, acetylsalicyliclysine using the dosages 0.9 g/48 h, 1.8 g/24 h and 3.6 g/24 h, was examined in order to see its effect in preventing deep vein thrombosis (DVT) after elective hip joint surgery. DVT was diagnosed by the 125-I-fibrinogen-test.
No reduction of postoperative DVT was found under any of the administered AS-lysine dosages.
The collagen-induced platelet aggregation was significantly decreased in all three groups. However, under the low AS-lysine dosages, aggregation was less inhibited with the incidence of DVT than without DVT. In the group with the 3.6 g-dosage, aggregation was maximally inhibited, without any significant difference related to the occurrence of DVT.
The results reveal no therapeutic range of AS-lysine to prevent postoperative venous thrombosis.
Zusammenfassung
Acetylsalicyl-lysin wurde in den Dosierungen 0,9 g/48 h, 1,8 g/24 h und 3,6 g/24 h in drei nacheinander folgenden Studien zur Thromboseprophylaxe bei Hüftgelenksoperationen anhand des Radio-Fibrinogen-Tests untersucht. Mit den drei AS-lysin-Dosierungen wurde keine Verminderung von Thrombosen (TVT) gefunden.
Die Kollagen-induzierte Thrombozytenaggregation war in allen drei Gruppen signifikant gesenkt. Unter den niedrigen AS-lysin-Dosen war die Aggregation beim Auftreten einer TVT weniger stark gehemmt als beim Ausbleiben einer TVT. Bei der 3,6 g-Dosis war die Aggregation maximal ohne signifikante Unterschiede vom Thrombosevorkommen gehemmt.
Die Befunde ergeben keinen therapeutischen Bereich für die Acetylsalicylsäure zur Verhütung venöser Thrombosen.
Similar content being viewed by others
Literatur
Al-Monhiri, H., Marcus, A.J., Spaet, T.H.: On the mechanism of platelet function inhibition by acetylsalicylic acid. Proc. Soc. exper. Biol. Med.133, 632 (1970)
Bockslaff, H., Barthels, M., Stolle, E., Trentz, O., Wuppermann, Th., Zech, G.: Frühdiagnose von Beinvenenthrombosen mit dem Radiofibrinogentest bei Patienten mit alloplastischem Hüftgelenkersatz. Münch. med. Wschr.116, 1397 (1974)
Born, G.V.R.: Quantitative investigation into aggregation of blood platelets. J. Physiol.162, 67 (1962)
Breddin, K., Scharrer, I., Schepping, M.: Die Hemmung der Plättchenaggregation mit Azetylsalizylsäure. Münch. med. Wschr.113, 1284 (1971)
British Medical Research Council: Effect of aspirin on postoperative venous thrombosis. Report of the Steering Committee. LancetII, 441 (1972)
Dechavanne, M., Ville, D., Viala, J.J., Kher, A., Faivre, J., Pusset, M.B., Dejour, H.: Controlled trial of platelet antiaggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients. Haemostasis4, 94 (1975)
Encke, A., Stock, C., Dumke, H.O.: Doppelblindstudie zur postoperativen Thromboseprophylaxe mit Dipyridamol/Acetylsalicylsäure. Chirurg47, 670 (1976)
Evans, G., Packham, M.A., Nishizawa, E.E., Mustard, J.F., Murphy, E.A.: The effect of acetylsalicylic acid on platelet function. J. Exp. Med.128, 877 (1968)
Farbiszewski, R., Niewiarowski, S., Worowski, K., Lipinski, B.: Release of platelet factor 4 in vivo during intravascular coagulation and in thrombotic states. Thrombos. Diathes. haemorrh.19, 578 (1968)
Hamberg, M., Svenson, J., Wakabayashi, T., Samuelsson, B.: Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc. Nat. Acad. Sci.71, 345 (1974)
Harris, W.H., Salzman, E.W., Athansoulis, C., Waltman, A.C., Baum, S., DeSanctis, R.W.: Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutanous heparin in prevention of venous thromboembolism following total hip replacement. J. Bone and Joint Surg.56, 1552 (1974)
Heinrich, H., Róka, L.: Methode zur Bestimmung der Thrombocytenaggregation. Klin. Wschr.48, 235 (1970)
Hey, D., Heinrich, D., Burckhardt, H.: Zur Prophylaxe thromboembolischer Komplikationen bei großen Hüftgelenkseingriffen. Münch. med. Wschr.115, 1967 (1973)
Jennings, J.J., Harris, W.H., Sarmiento, A.: A clinical evaluation of aspirin prophylaxis of thromboembolic disease after total hip arthoplasty. J. Bone Joint Surg.58-A, 926 (1976)
Kakkar, V.V., Nicolaides, A.N., Renney, J.T.G., Friend, J.R., Clarke, M.B.: 125 J-labelled fibrinogen test adapted for routine screening for deep-vein thrombosis. LancetI, 540 (1970)
Loew, D., Wellmer, H.-K., Baer, U., Merguet, H., Rumpf, P., Persch, W.F., Marx, F.J., von Bary, S.M.: Postoperative Thromboembolie-Prophylaxe mit Acetylsalicylsäure. Dtsch. med. Wschr.99, 565 (1974)
Matt, E.M., Gruber, U.F.: Prophylaxe postoperativer thromboembolischer Komplikationen mit subkutan verabreichten kleinen Heparin-Dosen. Fortschr. Med.95, 669 (1977)
Meng, K.: Tierexperimentelle Thrombose und Behandlung mit Acetylsalicylsäure. Med. Welt27(N.F.), 1359 (1976)
Morris, C.D.W.: Observations on the effect of glass beads on platelet aggregation and its relation to platelet stickiness. Thrombos. Diathes. haemorrh.20, 345 (1968)
Morris, G.K., Mitchell, J.R.A.: Preventing venous thromboembolism in elderly patients with hip fractures: studies of low-dose heparin, dipyridamole, aspirin, and flurbiprofen. Brit. med. J.1, 535 (1977)
Negus, D., Pinto, D.J., La Quesne, L.P., Brown, N., Chapman, M.: 125-I-labelled fibrinogen in the diagnosis of deep-vein thrombosis and its correlation with phlebography. Brit. J. Surg.55, 835 (1968)
Nicolaides, A.N., Irving, D.: Clinical factors and the risk of deep venous thrombosis. In: Thromboembolism, Aetiology, Advances in Prevention and Management. Hrsg.: A.N. Nicolaides, Medical and Technical Publishing Co. Ltd. (1975)
O'Brien, J.R.: Effects of salicylates on human platelets. LancetI, 779 (1968)
O'Brien, J.R.: Detection of thrombosis with iodine-125 fibrinogen. LancetII, 396 (1970)
Pinto, D.J.: Controlled trial of an anticoagulant (warfarin sodium) in the prevention of venous thrombosis following hip surgery. Brit. J. Surg.57, 349 (1970)
Quick, A.J.: Salicylates and bleeding: The aspirin tolerance test. Amer. J. Med. Sci.252, 265 (1966)
Renny, J.T.G., O'Sullivan, E.F., Burke, P.F.: Prevention of postoperative deep vein thrombosis with dipyridamol and aspirin. Brit. med. J.1, 992 (1976)
Salzman, E.W., Harris, W.H., DeSanctis, R.W.: Reduction in venous thromboembolism by agents affecting platelet function. N. Engl. J. Med.284, 1287 (1971)
Schöndorf, T.H., Hey, D.: Wirksamkeit von subkutan verabreichtem Heparin zur Thromboseprophylaxe bei großen Hüftgelenkseingriffen. Kontrollierte Studie. Dtsch. med. Wschr.100, 2014 (1975)
Schöndorf, T.H., Hey, D.: Gerinnungsanalytische Untersuchungen zur Thrombogenese bei großen Hüftgelenksoperationen. Inn. Med.3, 365 (1976)
Schöndorf, T.H., Hey, D.: Combined administration of low dose heparin and aspirin as prophylaxis of deep vein thrombosis after hip joint surgery. Haemostasis5, 250 (1976)
Schöndorf, T.H., Hey, D.: Aussagekraft von Kontrollmethoden zur postoperativen Überwachung einer Acetylsalicyl-lysin-und Heparinmedikation. Münch. med. Wschr.119, 119 (1977)
Schöndorf, T.H., Weber, U., Lasch, H.G.: Niedrig dosiertes Heparin und Acetylsalicylsäure nach elektiven Operationen am Hüftgelenk. Dtsch. med. Wschr.102, 1314 (1977)
Schöndorf, T.H.: Klinische und gerinnungsphysiologische Untersuchungen zur Thromboseprophylaxe bei großen Hüftgelenksoperationen. Habilitationsschrift, Gießen (1977)
Schöndorf, T.H., Hey, D.: Modified “low-dose” heparin prophylaxe to reduce thrombosis after hip joint operations. Thrombos. Res.12, 153 (1978)
Smith, J.B., Willis, A.L.: Aspirin selectively inhibits prostaglandin production in human platelets. Nature New Biol.231, 235 (1971)
Soreff, J., Johnsson, H., Diener, L., Göransson, L.: Acetylsalicylic acid in a trial to diminish thromboembolic complications after elective hip surgery. Acta orthop. Scand.46, 246 (1975)
Weber, W., Wolff, V., Bromig, G.: Postoperative Thromboembolie-Prophylaxe mit Colfarit®. Therapeut. Bericht43, 229 (1971)
Weiss, H.J., Aledort, L.M., Kochwa, S.: The effect of salicylates on the hemostatic properties of platelet in man. J. Clin. Invest.47, 2169 (1968)
Wood, E.H., Prentice, C.R.M., McGrouther, D.A., Sinclair, J., McNicol, G.P.: Trial of aspirin and RA 233 in prevention of post-operative deep vein thrombosis. Thrombos. Diath. haemorrh.30, 18 (1973)
Youssef, A.H., Barkhan, P.: Inhibition by aspirin of release antiheparin activity from human platelets. Brit. med. J.3, 394 (1969)
Zekert, F., Kohn, P., Vormittag, E., Poigenfürst, J., Thien, M.: Thromboembolieprophylaxe mit Acetylsalicylsäure bei Operationen wegen hüftgelenksnaher Frakturen. Mschr. Unfallheilk.77, 97 (1974)
Zucker, M.B., Peterson, J.: Inhibition of adenosin diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proc. Soc. exp. Biol.127, 547 (1968)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schöndorf, T.H., Hey, D. & Lasch, H.G. Klinische und in vitro-Untersuchungen zur therapeutischen Breite von Acetylsalicylsäure zur Thromboseprophylaxe. Klin Wochenschr 56, 1113–1118 (1978). https://doi.org/10.1007/BF01477133
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01477133